Zenotech Laboratories share news, announcements and annual reports
BSE: 532039Pharmaceuticals & BiotechnologySmall Cap
Zenotech Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1996
Last close ₹37.95up ₹0.15 (0.40%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹37.80.
29 Oct: open ₹38.06, high ₹39.20, low ₹36.92
52-week range of traded prices to 29 Oct 2026
₹33.55Low, 30 Mar 2026₹54.14High, 31 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹232 Cr2,190th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.51
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −8.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 19,861
Zenotech Laboratories board meetings
93 filed, newest first. Page 1 of 2.
Oct 2026
19 Oct · Board meeting
Meeting on 28 Oct 2026: quarterly results
Jul 2026
13 Jul · Board meeting
Meeting on 28 Jul 2026: quarterly results
Apr 2026
23 Apr · Board meeting
Meeting on 29 Apr 2026: audited results and quarterly results
Jan 2026
16 Jan · Board meeting
Meeting on 23 Jan 2026: quarterly results
Oct 2025
23 Oct · Board meeting
Meeting on 31 Oct 2025: quarterly results
Sep 2025
25 Sep · Board meeting
Meeting on 25 Sep 202525 Sep · Board meeting
Jul 2025
21 Jul · Board meeting
Meeting on 28 Jul 2025: quarterly results
Apr 2025
21 Apr · Board meeting
Meeting on 25 Apr 2025: audited results
Jan 2025
20 Jan · Board meeting
Meeting on 28 Jan 2025: quarterly results
Oct 2024
17 Oct · Board meeting
Meeting on 23 Oct 2024: quarterly results
Jul 2024
26 Jul · Board meeting
18 Jul · Board meeting
Meeting on 26 Jul 2024: quarterly results
May 2024
Apr 2024
24 Apr · Board meeting
Meeting on 1 May 2024: audited results
Jan 2024
17 Jan · Board meeting
Meeting on 29 Jan 2024: quarterly results
Oct 2023
20 Oct · Board meeting
Meeting on 30 Oct 2023: quarterly results
Jul 2023
25 Jul · Board meeting
Meeting on 1 Aug 2023: quarterly results
Apr 2023
21 Apr · Board meeting
Meeting on 28 Apr 2023: audited results
Jan 2023
19 Jan · Board meeting
Meeting on 27 Jan 2023: quarterly results
Oct 2022
20 Oct · Board meeting
Meeting on 28 Oct 2022: quarterly results
Jul 2022
14 Jul · Board meeting
Meeting on 22 Jul 2022: quarterly results
Apr 2022
22 Apr · Board meeting
Meeting on 29 Apr 2022: audited results
Jan 2022
18 Jan · Board meeting
Meeting on 28 Jan 2022: quarterly results
Oct 2021
14 Oct · Board meeting
Meeting on 22 Oct 2021: quarterly results